PLRZ
Polyrizon Ltd.
NASDAQ · Healthcare · Biotechnology · IL
$11.24
−10.51%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
-3.3%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Mar 31, 2026 | Carmel Liron · director | Sale | 100 | $11 |
| Mar 31, 2026 | Izraeli Tomer · director, officer: Chief Executive Officer | Sale | 3,900 | $11 |
| Mar 31, 2026 | Turgeman Tidhar · director, officer: Chief Technology Officer | Sale | 2,917 | $11 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Mar 31, 2026